25-methoxydammarane-3,12,20-triol

Subscribe to Selected New Research on 25-methoxydammarane-3,12,20-triol

1 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: a phytogenic antineoplastic agent isolated from Panax notoginseng; structure in first source

Also Known As:

20(S)-25-OCH3-PPD; 20(S)-25-methoxyl-dammarane-3beta,12beta,20-triol

Bio-Agent Context: Research Results

Organic Chemicals: 40

Hydrocarbons: 382

Terpenes: 149

Triterpenes: 64

25-methoxydammarane-3,12,20-triol: 1

Related Diseases

1.	Neoplasms (Cancer) 01/01/2007 - "The data presented here may provide a basis for the future development of 20(S)-25-OCH3-PPD as a novel anti-cancer agent." 01/01/2007 - "The biological activities of 20(S)-25-OCH3-PPD and its known analogs, 20(S)-PPD and Rg3, were evaluated in 12 human cancer cell lines" 01/01/2007 - "Herein we report the discovery and characterization of 20(S)-25-OCH3-PPD, a ginsenoside that inhibits growth and survival of cancer cells" Get all the results and reference details, order at left...
2.	Breast Neoplasms (Breast Cancer) 01/01/2007 - "20(S)-25-OCH3-PPD also induced apoptosis and cell cycle arrest in the G1 phase, and inhibited proliferation in breast cancer cell lines, demonstrating its potent biological effects" Get all the results and reference details, order at left...
2 Diseases and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>